Venoruton

Country of origin - Switzerland, Novartis Consumer Health S.A. (Switzerland), Novartis Pharmaceuticals S.A. (Spain)

Pharm group - Rutin group (vitamin P)

Manufacturers - Zima SA (Switzerland), Novartis Consumer Health S.A. (Switzerland), Novartis Pharmaceuticals S.A. (Spain)

International name - Rutozid

Synonyms - Venoruton forte, Rutin

Dosage forms - capsules 300 mg, injection solution 10%, gel 2%

Composition - Active substance - rutoside.

Indications for use - Varicose veins, superficial thrombophlebitis, chronic venous insufficiency (pain, swelling, trophic disorders, ulcers, etc.), hemorrhoids, post-thrombotic syndrome, retinopathy (diabetic, hypertensive, atherosclerotic), lymphostasis, trophic disorders after radiation therapy, pain and swelling due to injuries (gel).

Contraindications - Hypersensitivity. Restrictions on use: Pregnancy (1st trimester).

Side effects - Dyspeptic symptoms, headache, hot flashes, allergic skin rashes, local skin reactions (gel).

Interaction - No data available.

Overdose - No data.

Special instructions - No data.

Literature - 1. Register of Medicines 2004. 2. Register of Medicines 2000.